AC102-Suspension 12 mg/ml, placebo gel, Placebo matching Prednisolone, Prednisolon 10 mg GALEN®
AC102-201
Phase 2 small_molecule active
Quick answer
AC102-Suspension 12 mg/ml, placebo gel, Placebo matching Prednisolone, Prednisolon 10 mg GALEN® for Idiopathic Sudden Sensorineural Hearing Loss is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Idiopathic Sudden Sensorineural Hearing Loss
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active